Berberine as a Potential Anticancer Agent: A Comprehensive Review
Abdur Rauf,Tareq Abu-Izneid,Anees Ahmed Khalil,Muhammad Imran,Zafar Ali Shah,Talha Bin Emran,Saikat Mitra,Zidan Khan,Fahad A. Alhumaydhi,Abdullah S. M. Aljohani,Ishaq Khan,Mominur Rahman,Philippe Jeandet,Tanweer Aslam Gondal,Md. Mominur Rahman
DOI: https://doi.org/10.3390/molecules26237368
IF: 4.6
2021-12-04
Molecules
Abstract:Berberine (BBR), a potential bioactive agent, has remarkable health benefits. A substantial amount of research has been conducted to date to establish the anticancer potential of BBR. The present review consolidates salient information concerning the promising anticancer activity of this compound. The therapeutic efficacy of BBR has been reported in several studies regarding colon, breast, pancreatic, liver, oral, bone, cutaneous, prostate, intestine, and thyroid cancers. BBR prevents cancer cell proliferation by inducing apoptosis and controlling the cell cycle as well as autophagy. BBR also hinders tumor cell invasion and metastasis by down-regulating metastasis-related proteins. Moreover, BBR is also beneficial in the early stages of cancer development by lowering epithelial–mesenchymal transition protein expression. Despite its significance as a potentially promising drug candidate, there are currently no pure berberine preparations approved to treat specific ailments. Hence, this review highlights our current comprehensive knowledge of sources, extraction methods, pharmacokinetic, and pharmacodynamic profiles of berberine, as well as the proposed mechanisms of action associated with its anticancer potential. The information presented here will help provide a baseline for researchers, scientists, and drug developers regarding the use of berberine as a promising candidate in treating different types of cancers.
chemistry, multidisciplinary,biochemistry & molecular biology